Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
COCH antisense RNA 1 (COCH-AS1) is a long non-coding RNA transcribed in the antisense direction from the COCH gene locus. Like other antisense lncRNAs, its primary role is thought to be the cis- or trans-regulation of gene expression through a variety of mechanisms, including modulation of chromatin state, transcriptional interference, or RNA stability[1][2][5][8]. Most antisense lncRNAs are involved in complex regulatory networks and can affect processes such as development, stress response, or disease-relevant pathways[1][2][8]. There are no reports associating COCH-AS1 directly with specific diseases, therapeutic targeting, or established biological functions. As such, information on this specific lncRNA is limited, and generalizations are made from the broader class of antisense lncRNAs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on COCH antisense RNA 1 (COCH-AS1).